John J Mason
Examiner (ID: 6497)
Most Active Art Unit | 2198 |
Art Unit(s) | 2198 |
Total Applications | 1 |
Issued Applications | 1 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6705912
[patent_doc_number] => 20030152646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Method of treating conditions caused by activated microglia'
[patent_app_type] => new
[patent_app_number] => 10/316372
[patent_app_country] => US
[patent_app_date] => 2002-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10045
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10316372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/316372 | Method of treating conditions caused by activated microglia | Dec 10, 2002 | Abandoned |
Array
(
[id] => 7378766
[patent_doc_number] => 20040028656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Survival of neurons'
[patent_app_type] => new
[patent_app_number] => 10/313915
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16751
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313915 | Survival of neurons | Dec 5, 2002 | Abandoned |
Array
(
[id] => 6846770
[patent_doc_number] => 20030165937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Blood-based assay for dysferlinopathies'
[patent_app_type] => new
[patent_app_number] => 10/306662
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8865
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165937.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306662 | Blood-based assay for dysferlinopathies | Nov 26, 2002 | Issued |
10/169181 | Nucleic acids and polypeptides of invertebrate cell surface receptors and methods of use | Nov 25, 2002 | Abandoned |
Array
(
[id] => 5662081
[patent_doc_number] => 20060252677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Postsynaptic proteins'
[patent_app_type] => utility
[patent_app_number] => 10/496224
[patent_app_country] => US
[patent_app_date] => 2002-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27481
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496224
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496224 | Postsynaptic proteins | Nov 19, 2002 | Abandoned |
Array
(
[id] => 6710992
[patent_doc_number] => 20030170741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Methods for identifying compounds for regulating muscle mass or function using dopamine receptors'
[patent_app_type] => new
[patent_app_number] => 10/299642
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19612
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299642 | Methods for identifying compounds for regulating muscle mass or function using dopamine receptors | Nov 17, 2002 | Issued |
10/285655 | Protein-protein interactions and use thereof | Oct 29, 2002 | Abandoned |
Array
(
[id] => 6766105
[patent_doc_number] => 20030100505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Compositions and methods of therapy for IGF-I-responsive conditions'
[patent_app_type] => new
[patent_app_number] => 10/279343
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9412
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10279343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/279343 | Compositions and methods of therapy for IGF-I-responsive conditions | Oct 23, 2002 | Abandoned |
Array
(
[id] => 7362556
[patent_doc_number] => 20040005309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Targeted therapeutic proteins'
[patent_app_type] => new
[patent_app_number] => 10/272531
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23902
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272531
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272531 | Targeted therapeutic proteins | Oct 15, 2002 | Abandoned |
Array
(
[id] => 7362446
[patent_doc_number] => 20040005291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Methods for regulating co-stimulatory molecule expression with reactive oxygen'
[patent_app_type] => new
[patent_app_number] => 10/272432
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15733
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005291.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272432 | Methods for regulating co-stimulatory molecule expression with reactive oxygen | Oct 14, 2002 | Abandoned |
Array
(
[id] => 6855633
[patent_doc_number] => 20030129134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Method of monitoring neuroprotective treatment'
[patent_app_type] => new
[patent_app_number] => 10/268465
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11646
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268465
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268465 | Method of monitoring neuroprotective treatment | Oct 9, 2002 | Abandoned |
Array
(
[id] => 6830653
[patent_doc_number] => 20030181711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1'
[patent_app_type] => new
[patent_app_number] => 10/264171
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 103276
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10264171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/264171 | Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1 | Oct 2, 2002 | Abandoned |
Array
(
[id] => 6782635
[patent_doc_number] => 20030064082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Antipsychotic agents stimulate neurogenesis in brain'
[patent_app_type] => new
[patent_app_number] => 10/262996
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8825
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10262996
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/262996 | Antipsychotic agents stimulate neurogenesis in brain | Oct 1, 2002 | Abandoned |
Array
(
[id] => 582264
[patent_doc_number] => 07445904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-04
[patent_title] => 'Cysteine string protein and its role in neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 10/255989
[patent_app_country] => US
[patent_app_date] => 2002-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 69
[patent_no_of_words] => 15356
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/445/07445904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10255989
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/255989 | Cysteine string protein and its role in neurodegenerative diseases | Sep 25, 2002 | Issued |
Array
(
[id] => 6847388
[patent_doc_number] => 20030166555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Methods and compositions for regulating memory consolidation'
[patent_app_type] => new
[patent_app_number] => 10/251661
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21456
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251661 | Methods and compositions for regulating memory consolidation | Sep 19, 2002 | Abandoned |
Array
(
[id] => 6668875
[patent_doc_number] => 20030113859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245737
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44991
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245737 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6817823
[patent_doc_number] => 20030068781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245771
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 41243
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245771 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6683272
[patent_doc_number] => 20030119136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245881
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44977
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245881
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245881 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |
Array
(
[id] => 5721452
[patent_doc_number] => 20060074228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/243136
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 40772
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10243136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243136 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 11, 2002 | Abandoned |
Array
(
[id] => 6761301
[patent_doc_number] => 20030124663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/243255
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44992
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10243255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243255 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 11, 2002 | Abandoned |